Idefirix 11 mg, poudre pour solution à diluer pour perfusion - 2 Swissmedic Key 68373002 Registration Holder iQone Healthcare Switzerland SA Name Idefirix 11 mg, poudre pour solution à diluer pour perfusion Date of registration 06.05.2022 Introduction of Sequence 06.05.2022 ATC-Classification Imlifidase (L04AA41) Revision date WHO WHO-DDD Valid until 06.05.2026 Index Therapeuticus (BSV) 07.15. Show package size 2 Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680683730024 Medication Code Biotechnologika Pharmacode Disponibility
Composition imlifidasum 11 mg, mannitolum, polysorbatum 80, trometamolum, dinatrii edetas, acidum hydrochloridum, pro vitro corresp. natrium 0.004 mg. Packungsbestandteile Galenic Form poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Imlifidasum 11 mg
BAG: Active Agent Dose Imlifidasum 11 mg
Inactive agents Acidum Hydrochloridum Dinatrii Edetas Mannitol Polysorbatum 80 Trometamol
Source Data was imported : 04.05.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
